Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (3)

2023

  1. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593

2022

  1. Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 245-252

  2. Liver Brain Interactions: Focus on FGF21 a Systematic Review

    International Journal of Molecular Sciences, Vol. 23, Núm. 21